Skip to content

CapEx at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$8.18M-37.9%
Viatris logo
ViatrisVTRS
$39.9M-6.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$17K-51.4%
ALN
Alnylam PharmaceuticalsALNY
$21.83M+143%
Amgen logo
AmgenAMGN
$712M+73.2%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$23K-73.3%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's capex?
ANI Pharmaceuticals (ANIP) reported capex of $6.07M in Q1 2026.
How has ANI Pharmaceuticals's capex changed year-over-year?
ANI Pharmaceuticals's capex increased by 145.5% year-over-year, from $2.47M to $6.07M.
What is the long-term trend for ANI Pharmaceuticals's capex?
Over 4 years (2021 to 2025), ANI Pharmaceuticals's capex has grown at a 52.5% compound annual growth rate (CAGR), from $2.56M to $13.84M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.